Home
ArticlesArticlesLabman and TMRW partner for CryoRobot to revolutionize IVF labs with secure, automated cryogenic storage and RFID-enabled sample tracking. The partnership brings safety and efficiency gains, setting a new standard for fertility clinics worldwide.
TMRW Life Sciences and Labman have developed a next-generation IVF specimen storage and retrieval system that integrates biometric scanning, a custom cryogenic tank, and end-to-end digital tracking to improve safety, efficiency, and scalability in embryology labs. The CE‑marked CryoRobot Select aligns with FDA requirements, multiple ISO standards, and GDPR, and is now embedded in TMRW’s product pipeline for global deployment.
Conventional IVF workflows are vulnerable to mishandling, inefficient tracking, and suboptimal storage conditions that compound risk as frozen inventories grow, prompting an automation-first redesign of cryostorage management. The CryoRobot Select was engineered to directly address these gaps by reducing manual touchpoints, standardizing conditions, and creating a verifiable digital chain of custody at the sample level.
The platform pairs purpose-built hardware, a tailored cryogenic storage tank, and a robotic picker with software-enabled specimen identification using RFID tags unique to each patient sample. Embryologists gain global, real-time visibility and auditability over eggs and embryos, supported by biometric access control and continuous system checks to maintain optimal temperature and handling conditions.
In testing and verification, the technology demonstrated safer, more controlled handling environments for eggs and embryos stored within the TMRW ecosystem, providing added assurance to clinics and patients. Reported operational benefits include substantial reductions in storage and retrieval cycle times, consistent with automation-driven efficiencies that minimize potential points of failure compared with manual systems.
The CryoRobot Select received the EU CE Mark following FDA clearance, meeting rigorous safety and performance standards under European Medical Device Regulations and aligning with multiple ISO frameworks. The system’s data practices are designed to comply with GDPR and to support EMR integration and audit-ready traceability across the IVF laboratory workflow.
TMRW’s device engineering leadership highlights that replacing the earlier-generation automation with CryoRobot Select enables expansion into more clinics and markets thanks to a smaller footprint, shorter cycle times, and reduced user handling. The collaboration emphasized a risk-based development process to protect both the patient and specimen at every step of storage and retrieval.
This collaboration shows how specialized automation engineering and fertility technology can be combined to harden critical lab processes while simplifying daily operations for embryologists. As demand for cryopreservation scales, clinics adopting automated storage with digital specimen management are positioned to reduce errors, improve throughput, and strengthen patient confidence in chain-of-custody and safety controls.
Labman and TMRW partner for CryoRobot to establish a new benchmark for IVF cryostorage: high-volume capacity, precise tracking, and robust compliance in a compact, deployable form factor for global labs. By elevating consistency and accountability in the most sensitive stages of IVF, Labman and TMRW partner for CryoRobot to align clinical operations with the scale and expectations of modern fertility care. Ultimately, Labman and TMRW partner for CryoRobot to make specimen management safer and more efficient while reinforcing trust through demonstrable, digital traceability.
The Egg Retrieval Procedure details its importance in the In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) processes for collecting mature eggs for fertilization. It outlines the steps involved in the Egg Retrieval Procedure, including ovarian stimulation, the actual retrieval method, and post-procedure care while addressing potential risks and complications.
Assess quality when seeking low-cost fertility treatments abroad, emphasizing the importance of clinic accreditation and medical expertise. It emphasises the value of transparency in pricing and services, encouraging patients to research low-cost fertility treatments thoroughly to avoid hidden fees. Patient reviews and communication with healthcare providers are crucial factors in ensuring a positive experience and successful outcomes in fertility tourism.
Guidance on why first IVF cycles fail, how to adjust protocols, when to consider donor gametes or PGT-A, and how to plan emotionally and financially for retries to improve cumulative success.
The additional fertility treatment costs that individuals and couples may encounter, including medications, egg/sperm freezing, and genetic testing. Understanding these additional fertility treatment costs is crucial for effective financial planning during the fertility journey.
The Czech Republic has emerged as Europe’s IVF affordability hub, offering world-class fertility treatment at nearly half the cost of Western Europe. With regulated clinics, transparent pricing, and high success rates, it stands as a trusted destination for patients seeking ethical, safe, and affordable assisted reproduction.
How sleep quality affects IVF success, examining hormonal changes, ovarian response, embryo quality, and pregnancy risks, while highlighting emerging clinical research and lifestyle strategies that improve reproductive outcomes.
The various factors affecting In Vitro Fertilization (IVF) success rates, highlighting the significant roles of age, health, and lifestyle choices in achieving successful outcomes. It emphasises that optimising these factors can significantly improve an individual's or couple's chances of conceiving through IVF.
